Fusion of engineered albumin with factor IX Padua extends half‐life and improves coagulant activity-Reference-Cited by-同舟云学术

Fusion of engineered albumin with factor IX Padua extends half‐life and improves coagulant activity

Published:2021-06-09 Issue:2 Volume:194 Page:453-462
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Lombardi Silvia¹^ORCID,Aaen Kristin H.²³^ORCID,Nilsen Jeannette²³^ORCID,Ferrarese Mattia¹^ORCID,Gjølberg Torleif T.²³⁴,Bernardi Francesco¹^ORCID,Pinotti Mirko¹^ORCID,Andersen Jan T.²³^ORCID,Branchini Alessio¹^ORCID

Affiliation:

1. Department of Life Sciences and Biotechnology and LTTA Centre University of Ferrara Ferrara Italy

2. Department of Immunology University of Oslo and Oslo University Hospital Rikshospitalet OsloNorway

3. Institute of Clinical Medicine and Department of Pharmacology University of Oslo and Oslo University Hospital OsloNorway

4. Department of Ophthalmology University of Oslo and Oslo University Hospital Oslo Norway

Funder

Bayer Foundation

Norges Forskningsråd

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17559

Reference60 articles.

1. Haemophilias A and B

2. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

3. Optimal haemophilia care versus the reality

4. Recent advances in developing specific therapies for haemophilia

5. Prolonged activity of factor IX as a monomeric Fc fusion protein

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor IX stimulants in preclinical and early phase trials for hemophilia B treatment;Expert Opinion on Investigational Drugs;2024-08-11

2. Russia's attacks on civilians strengthen Ukrainian resistance;PNAS Nexus;2023-12-01

3. A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery;PNAS Nexus;2023-11-28

4. Nanostructured proteins for delivering drugs to diseased tissues;Bioinspired, Biomimetic and Nanobiomaterials;2023-09-01

5. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment;European Journal of Pharmaceutical Sciences;2022-09